[go: up one dir, main page]

AU3886200A - Methods of treating alzheimer's disease and other amyloidoses using hypericum perforatum and derivatives thereof - Google Patents

Methods of treating alzheimer's disease and other amyloidoses using hypericum perforatum and derivatives thereof

Info

Publication number
AU3886200A
AU3886200A AU38862/00A AU3886200A AU3886200A AU 3886200 A AU3886200 A AU 3886200A AU 38862/00 A AU38862/00 A AU 38862/00A AU 3886200 A AU3886200 A AU 3886200A AU 3886200 A AU3886200 A AU 3886200A
Authority
AU
Australia
Prior art keywords
amyloidoses
disease
derivatives
methods
treating alzheimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38862/00A
Inventor
Gerardo Castillo
Alan D. Snow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProteoTech Inc
Original Assignee
ProteoTech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProteoTech Inc filed Critical ProteoTech Inc
Publication of AU3886200A publication Critical patent/AU3886200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/38Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
AU38862/00A 1999-03-15 2000-03-15 Methods of treating alzheimer's disease and other amyloidoses using hypericum perforatum and derivatives thereof Abandoned AU3886200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12446399P 1999-03-15 1999-03-15
US60124463 1999-03-15
PCT/US2000/006814 WO2000057707A1 (en) 1999-03-15 2000-03-15 Methods of treating alzheimer's disease and other amyloidoses using hypericum perforatum and derivatives thereof

Publications (1)

Publication Number Publication Date
AU3886200A true AU3886200A (en) 2000-10-16

Family

ID=22415047

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38862/00A Abandoned AU3886200A (en) 1999-03-15 2000-03-15 Methods of treating alzheimer's disease and other amyloidoses using hypericum perforatum and derivatives thereof

Country Status (2)

Country Link
AU (1) AU3886200A (en)
WO (1) WO2000057707A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10702571B2 (en) 2015-12-03 2020-07-07 The University Of North Carolina At Pembroke Materials for cathepsin B enhancement and methods of use

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999040905A2 (en) * 1998-02-13 1999-08-19 Dr. Willmar Schwabe Gmbh & Co. Use of hyperforin and hyperforin-containing extracts in the treatment and prophylaxis of dementing diseases
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
NZ544691A (en) 2000-11-03 2007-12-21 Proteotech Inc Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants
US20070208087A1 (en) 2001-11-02 2007-09-06 Sanders Virginia J Compounds, compositions and methods for the treatment of inflammatory diseases
AU2002250117B2 (en) * 2001-03-15 2007-11-29 Cognitive Clarity Inc. Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases
US7514107B2 (en) 2002-03-21 2009-04-07 Mars, Incorporated Treatment of diseases involving defective gap junctional communication
CA2486869C (en) 2002-05-31 2011-09-13 Proteotech, Inc. Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
US7414076B2 (en) 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
CA2592320C (en) 2004-12-22 2015-11-24 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
CA2659800A1 (en) * 2006-08-03 2008-02-07 Hy Biopharma Inc. Polycyclic dianthraquinones as inhibitors of inflammatory cytokines
ES2533463T3 (en) 2006-10-12 2015-04-10 Bhi Limited Partnership Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
WO2009087568A2 (en) * 2008-01-10 2009-07-16 Universidade De Coimbra Compositions comprising antioxidant and mitoprotective flavonoids with neuroprotective properties
PH12012501310A1 (en) 2009-12-23 2016-09-16 Finzelberg Gmbh And Co Kg Plant extracts for treating neurodegenerative diseases
PT2608798E (en) 2010-08-27 2015-03-26 Finzelberg Gmbh & Co Kg Plant extracts made of sideritis and use thereof to boost cognitive performance

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10702571B2 (en) 2015-12-03 2020-07-07 The University Of North Carolina At Pembroke Materials for cathepsin B enhancement and methods of use

Also Published As

Publication number Publication date
WO2000057707A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
CY2018020I2 (en) TREATMENT OF ROMRE'S DISEASE
AU2001249835A1 (en) Diagnosis and treatment of alzheimer's disease
AU3886200A (en) Methods of treating alzheimer's disease and other amyloidoses using hypericum perforatum and derivatives thereof
NO20004098D0 (en) Methods and preparations for the treatment of macrophage-mediated disorders
EP1392287B8 (en) Use of substituted azetidinone derivatives in the treatment of Alzheimer's disease
NO20010593L (en) Preparation and Procedure for the Treatment of Peyronie's Disease and Other Subdermal Plaque Manifestation Disorders
SI1303272T1 (en) Benzothiazole derivatives for the treatment of alzheimer's disease and parkinson's disease
AU3113500A (en) Compositions for treating alzheimer's disease and other amyloidoses
IL141429A0 (en) Compositions and methods for treatment of mitochondrial diseases
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
EE9900354A (en) A method of preventing and delaying the onset of Alzheimer's disease, and a composition thereof
AU3279395A (en) Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes
NO20002686L (en) Improvement of Peyronie's disease
NO20011409L (en) Pharmaceuticals for the treatment of Parkinson's disease, ADHD and microadenomas
AU2002239765A1 (en) Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
NO20001869D0 (en) Procedures for the treatment of Alzheimer's disease
AU6384099A (en) Blended compositions for treatment of alzheimer's disease and other amyloidoses
AU4078900A (en) Methods for tracking the progression of alzheimer's disease and identifying treatments using transgenic mice
AU2002222108A1 (en) Diagnosis and treatment of alzheimer's disease
PT932400E (en) DERIVATIVES OF USED ANTICONVULSIONERS IN THE TREATMENT OF NEUROPATIC PAIN
AU5550800A (en) Diagnosis and treatment of alzheimer's disease
AU2002215187A1 (en) S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease
AU7622798A (en) Application of thalidomide to the treatment of Parkinson's disease and Parkisonian syndromes
AUPN115095A0 (en) Analysis of and compositions and methods for the treatment of disease
NO971419L (en) Process for Preparation of 1,3-Alkenediols and 3-Hydroxyaldehydes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase